ADARB1 and cancer: Stably introduced in the genome of two cancer cell lines, MCF7 and HeLa, the reporter enables detection of elevated editing activity due to an activation of ADAR1p150 by interferon-alpha as well as reduced editing activity due to ADAR1 or ADAR2 silencing.